{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:14:24Z","timestamp":1792782864963,"version":"4.5.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:00:00Z","timestamp":1783382400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:00:00Z","timestamp":1783382400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Fresenius Medical Care Deutschland GmbH"},{"name":"Fresenius Medical Care Holdings Inc.","id":[{"id":"https:\/\/ror.org\/05rs7tq63","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s00467-026-07420-5","type":"journal-article","created":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T12:32:39Z","timestamp":1783427559000},"page":"4513-4523","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Impact of kidney maturation on aminoglycoside exposure in term-born pediatric patients: an in silico study"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-3219-067X","authenticated-orcid":false,"given":"Felix J.","family":"Meigel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Catalina","family":"Alvarez-El\u00edas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasha","family":"Hussein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doris H.","family":"Fuertinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,7]]},"reference":[{"key":"7420_CR1","doi-asserted-by":"publisher","unstructured":"De Cock RF, Allegaert K, Brussee JM, Sherwin CM, Mulla H, de Hoog M, van den Anker JN, Danhof M, Knibbe CA\u00a0(2014) Simultaneous pharmacokinetic modeling of gentamicin, tobramycin and vancomycin clearance from neonates to adults: towards a semi-physiological function for maturation in glomerular filtration. Eur J Pharm Sci 31:2643\u20132654. https:\/\/doi.org\/10.1007\/s11095-014-1361-z","DOI":"10.1007\/s11095-014-1361-z"},{"key":"7420_CR2","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1128\/aac.2.3.214","volume":"2","author":"RC Gordon","year":"1972","unstructured":"Gordon RC, Regamey C, Kirby WMM\u00a0(1972) Serum protein binding of the aminoglycoside antibiotics. Antimicrob Agents Chemother 2:214\u2013216.\u00a0https:\/\/doi.org\/10.1128\/aac.2.3.214","journal-title":"Antimicrob Agents Chemother"},{"key":"7420_CR3","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s00228-008-0599-y","volume":"65","author":"GM Pacifici","year":"2009","unstructured":"Pacifici GM (2009) Clinical pharmacokinetics of aminoglycosides in the neonate: a review. Eur J Clin Pharmacol 65:419\u2013427.\u00a0https:\/\/doi.org\/10.1007\/s00228-008-0599-y","journal-title":"Eur J Clin Pharmacol"},{"key":"7420_CR4","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1126\/science.118.3062.259","volume":"118","author":"SA Waksman","year":"1953","unstructured":"Waksman SA (1953) Streptomycin: background, isolation, properties, and utilization. Science 118:259\u2013266.\u00a0https:\/\/doi.org\/10.1126\/science.118.3062.259","journal-title":"Science"},{"key":"7420_CR5","doi-asserted-by":"publisher","first-page":"e111","DOI":"10.1542\/peds.114.1.e111","volume":"114","author":"DG Contopoulos-Ioannidis","year":"2004","unstructured":"Contopoulos-Ioannidis DG, Giotis ND, Baliatsa DV, Ioannidis JPA (2004) Extended-interval aminoglycoside administration for children: a meta-analysis. Pediatrics 114:e111\u2013e118.\u00a0https:\/\/doi.org\/10.1542\/peds.114.1.e111","journal-title":"Pediatrics"},{"key":"7420_CR6","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/0002-9343(86)90497-3","volume":"80","author":"GH McCracken","year":"1986","unstructured":"McCracken GH (1986) Aminoglycoside toxicity in infants and children. Am J Med 80:172\u2013178.\u00a0https:\/\/doi.org\/10.1016\/0002-9343(86)90497-3","journal-title":"Am J Med"},{"key":"7420_CR7","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1007\/s00467-016-3533-z","volume":"32","author":"SJ McWilliam","year":"2017","unstructured":"McWilliam SJ, Antoine DJ, Smyth RL, Pirmohamed M (2017) Aminoglycoside-induced nephrotoxicity in children. Pediatr Nephrol 32:2015\u20132025.\u00a0https:\/\/doi.org\/10.1007\/s00467-016-3533-z","journal-title":"Pediatr Nephrol"},{"key":"7420_CR8","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.3390\/ph16101353","volume":"16","author":"S Rivetti","year":"2023","unstructured":"Rivetti S, Romano A, Mastrangelo S, Attin\u00e0 G, Maurizi P,\u00a0 Ruggiero A (2023) Aminoglycosides-related ototoxicity: mechanisms, risk factors, and prevention in pediatric patients. Pharmaceuticals (Basel) 16:1370.\u00a0https:\/\/doi.org\/10.3390\/ph16101353","journal-title":"Pharmaceuticals (Basel)"},{"key":"7420_CR9","doi-asserted-by":"publisher","first-page":"dlae143","DOI":"10.1093\/jacamr\/dlae143","volume":"6","author":"E Nyaboke","year":"2024","unstructured":"Nyaboke E, Guantai A, Oluka M, Mutai B, Godman B, Kurdi A, Bennie M, Okumu M (2024) Nephrotoxicity associated with aminoglycoside therapy in paediatrics: experiences from a leading referral hospital in Kenya. JAC Antimicrob Resist 6:dlae143.\u00a0https:\/\/doi.org\/10.1093\/jacamr\/dlae143","journal-title":"JAC Antimicrob Resist"},{"key":"7420_CR10","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1007\/s13312-022-2475-8","volume":"59","author":"M Sravani","year":"2022","unstructured":"Sravani M, Krishnamurthy S, Parameswaran N, Rajappa M (2022) Assessment of causality in hospitalized children with aminoglycoside-related nephrotoxicity Indian. Pediatr 59:226\u2013229.\u00a0https:\/\/doi.org\/10.1007\/s13312-022-2475-8","journal-title":"Indian Pediatr"},{"key":"7420_CR11","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/j.jpeds.2014.04.058","volume":"165","author":"S Menon","year":"2014","unstructured":"Menon S, Kirkendall ES, Nguyen H, Goldstein SL (2014) Acute kidney injury associated with high nephrotoxic medication exposure leads to chronic kidney disease after 6 months. J Pediatr 165:522\u2013527.e2.\u00a0https:\/\/doi.org\/10.1016\/j.jpeds.2014.04.058","journal-title":"J Pediatr"},{"key":"7420_CR12","doi-asserted-by":"publisher","first-page":"e756","DOI":"10.1542\/peds.2013-0794","volume":"132","author":"SL Goldstein","year":"2013","unstructured":"Goldstein SL, Kirkendall E, Nguyen H, Schaffzin JK, Bucuvalas J, Bracke T, Seid M, Ashby M, Foertmeyer N, Brunner L, Lesko A, Barclay C, Lannon C, Muething S (2013) Electronic health record identification of nephrotoxin exposure and associated acute kidney injury. Pediatrics 132:e756\u2013e767.\u00a0https:\/\/doi.org\/10.1542\/peds.2013-0794","journal-title":"Pediatrics"},{"key":"7420_CR13","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.jpeds.2019.08.046","volume":"215","author":"C Stoops","year":"2019","unstructured":"Stoops C, Stone S, Evans E, Dill L, Henderson T, Griffin R, Goldstein SL, Coghill C, Askenazi DJ (2019) Baby NINJA (Nephrotoxic Injury Negated by Just-in-Time Action): reduction of nephrotoxic medication-associated acute kidney injury in the neonatal intensive care unit. J Pediatr 215:223\u2013228.e6.\u00a0https:\/\/doi.org\/10.1016\/j.jpeds.2019.08.046","journal-title":"J Pediatr"},{"key":"7420_CR14","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.kint.2019.10.015","volume":"97","author":"SL Goldstein","year":"2020","unstructured":"Goldstein SL, Dahale D, Kirkendall ES, Mottes T, Kaplan H, Muething S, Askenazi DJ, Henderson T, Dill L, Somers MJG, Kerr J, Gilarde J, Zaritsky J, Bica V, Brophy PD, Misurac J, Hackbarth R, Steinke J, Mooney J, Ogrin S, Chadha V, Warady B, Ogden R, Hoebing W, Symons J, Yonekawa K, Menon S, Abrams L, Sutherland S, Weng P, Zhang F, Walsh K (2020) A prospective multi-center quality improvement initiative (NINJA) indicates a reduction in nephrotoxic acute kidney injury in hospitalized children. Kidney Int 97:580\u2013588.\u00a0https:\/\/doi.org\/10.1016\/j.kint.2019.10.015","journal-title":"Kidney Int"},{"key":"7420_CR15","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.2215\/CJN.01640309","volume":"4","author":"GJ Schwartz","year":"2009","unstructured":"Schwartz GJ, Work DF (2009) Measurement and estimation of GFR in children and adolescents Clin J Am Soc Nephrol 4:1832\u20131843.\u00a0https:\/\/doi.org\/10.2215\/CJN.01640309","journal-title":"Clin J Am Soc Nephrol"},{"key":"7420_CR16","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1007\/s11095-024-03677-3","volume":"41","author":"Y Wu","year":"2024","unstructured":"Wu Y, Allegaert K, Flint RB, Goulooze SC, V\u00e4litalo PAJ, de Hoog M, Mulla H, Sherwin CMT, Simons SHP, Krekels EHJ, Knibbe CAJ, V\u00f6ller S\u00a0(2024) When will the glomerular filtration rate in former preterm neonates catch up with their term peers?. Pharm Res 41:637\u2013649.\u00a0https:\/\/doi.org\/10.1007\/s11095-024-03677-3","journal-title":"Pharm Res"},{"key":"7420_CR17","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1038\/ki.2011.123","volume":"80","author":"M Zappitelli","year":"2011","unstructured":"Zappitelli M, Krawczeski CD, Devarajan P, Wang Z, Sint K, Thiessen-Philbrook H, Li S, Bennett MR, Ma Q, Shlipak MG, Garg AX, Parikh CR, TRIBE-AKI Consortium (2011) Early postoperative serum cystatin C predicts severe acute kidney injury following pediatric cardiac surgery. Kidney Int 80:655\u2013662. https:\/\/doi.org\/10.1038\/ki.2011.123","journal-title":"Kidney Int"},{"key":"7420_CR18","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1208\/s12248-022-00688-z","volume":"24","author":"Y Wu","year":"2022","unstructured":"Wu Y, Allegaert K, Flint RB, Simons SHP, Krekels EHJ, Knibbe CAJ, V\u00f6ller S\u00a0(2022) Prediction of glomerular filtration rate maturation across preterm and term neonates and young infants using inulin as marker. AAPS J 24:38.\u00a0https:\/\/doi.org\/10.1208\/s12248-022-00688-z","journal-title":"AAPS J"},{"key":"7420_CR19","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1128\/aac.43.5.1003","volume":"43","author":"MP Mingeot-Leclercq","year":"1999","unstructured":"Mingeot-Leclercq MP, Tulkens PM (1999) Aminoglycosides: nephrotoxicity. Antimicrob Agents Chemother 43:1003\u20131012.\u00a0https:\/\/doi.org\/10.1128\/aac.43.5.1003","journal-title":"Antimicrob Agents Chemother"},{"key":"7420_CR20","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1038\/clpt.1985.245","volume":"38","author":"G Koren","year":"1985","unstructured":"Koren G, James A, Perlman M (1985) A simple method for the estimation of glomerular filtration rate by gentamicin pharmacokinetics during routine drug monitoring in the newborn. Clin Pharmacol Ther 38:680\u2013685.\u00a0https:\/\/doi.org\/10.1038\/clpt.1985.245","journal-title":"Clin Pharmacol Ther"},{"key":"7420_CR21","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1111\/bcp.12444","volume":"78","author":"A Fuchs","year":"2014","unstructured":"Fuchs A, Guidi M, Giannoni E, Werner D, Buclin T, Widmer N, Csajka C\u00a0(2014) Population pharmacokinetic study of gentamicin in a large cohort of premature and term neonates. Br J Clin Pharmacol 78:1090\u20131101.\u00a0https:\/\/doi.org\/10.1111\/bcp.12444","journal-title":"Br J Clin Pharmacol"},{"key":"7420_CR22","volume-title":"Pocket book of hospital care for children: guidelines for the management of common childhood illnesses","author":"World Health Organization","year":"2013","unstructured":"World Health Organization (2013) Pocket book of hospital care for children: guidelines for the management of common childhood illnesses. World Health Organization"},{"key":"7420_CR23","volume-title":"Manual of childhood infections: the blue book","author":"M Sharland","year":"2016","unstructured":"Sharland M, Butler K, Cant A, Dagan R, Davies G, Groot de D, Elliman S, Esposito A, Finn M, Galanakis C, Giaquinto J, Gray P, Heath T, Heikkinen U, Heininger P, Henneke I, Lutsar H, Lyall F, Martinon Torres A, Pollard M, Ramsay A, Riordan F, Rodrigues E, Roilides P, Rojo D, Shingadia S, Tomlin M, Tsolia M (2016) Manual of childhood infections: the blue book. Oxford University Press"},{"key":"7420_CR24","volume-title":"Red book 2018: report of the Committee on Infectious Diseases","author":"DW Kimberlin","year":"2018","unstructured":"Kimberlin DW, Brady MT, Long SS, Jackson MA, American Academy of Pediatrics Committee on Infectious Diseases (2018) Red book 2018: report of the Committee on Infectious Diseases. American Academy of Pediatrics"},{"key":"7420_CR25","doi-asserted-by":"publisher","first-page":"e015","DOI":"10.1097\/pq9.0000000000000015","volume":"2","author":"V Saddi","year":"2017","unstructured":"Saddi V, Preddy J, Dalton S, Connors J, Patterson S\u00a0(2017) Variation in gentamicin dosing and monitoring in pediatric units across New South Wales. Pediatr Qual Saf 2:e015.\u00a0https:\/\/doi.org\/10.1097\/pq9.0000000000000015","journal-title":"Pediatr Qual Saf"},{"key":"7420_CR26","doi-asserted-by":"publisher","first-page":"748","DOI":"10.3390\/antibiotics12050810","volume":"12","author":"EM Hollander","year":"2023","unstructured":"Hollander EM, van Tuinen EL, Sch\u00f6lvinck EH, Bergman KA, Bourgonje AR, Gracchi V, Kneyber MCJ, Touw DJ, Mian P\u00a0(2023) Evaluation of dosing guidelines for gentamicin in neonates and children. Antibiotics (Basel) 12:748.\u00a0https:\/\/doi.org\/10.3390\/antibiotics12050810","journal-title":"Antibiotics (Basel)"},{"key":"7420_CR27","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1007\/s40262-018-0641-x","volume":"57","author":"SM Illamola","year":"2018","unstructured":"Illamola SM, Sherwin CM, van Hasselt JGC\u00a0(2018) Clinical pharmacokinetics of amikacin in pediatric patients: a comprehensive review of population pharmacokinetic analyses. Clin Pharmacokinet 57:1217\u20131228.\u00a0https:\/\/doi.org\/10.1007\/s40262-018-0641-x","journal-title":"Clin Pharmacokinet"},{"key":"7420_CR28","unstructured":"U.S. Food and Drug Administration (2022) General clinical pharmacology considerations for pediatric studies of drugs, including biological products: draft guidance for industry. Silver Spring, MD: U.S. Food and Drug Administration. Available from: https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/general-clinical-pharmacology-considerations-pediatric-studies-drugs-including-biological-products. Accessed 7 Nov 2025"},{"key":"7420_CR29","unstructured":"European Medicines Agency (2006) Guideline on the role of pharmacokinetics in the development of medicinal products in the paediatric population. EMEA\/CHMP\/EWP\/147013\/2004. London: European Medicines Agency. Effective 1 Jan 2007. Available from: https:\/\/www.ema.europa.eu\/en\/role-pharmacokinetics-development-medicinal-products-paediatric-population-scientific-guideline. Accessed 7 Nov 2025"},{"key":"7420_CR30","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1002\/jcph.6116","volume":"64","author":"B Eales","year":"2024","unstructured":"Eales B, Helal NA, Vattelana O, Kronfol MM, Fletcher EP, Wang YM, Burckart GJ, Vaidyanathan J, Seo SK, Nounou MI\u00a0(2024) Population pharmacokinetics (PopPK) support for pediatric dosing of biological products. J Clin Pharmacol 64:1594\u20131605.\u00a0https:\/\/doi.org\/10.1002\/jcph.6116","journal-title":"J Clin Pharmacol"},{"key":"7420_CR31","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1136\/archdischild-2016-311674","volume":"102","author":"TM van der Zanden","year":"2017","unstructured":"van der Zanden TM, de Wildt SN, Liem Y, Offringa M, de Hoog M, Dutch Paediatric Pharmacotherapy Expertise Network NKFK (Nederlands Kenniscentrum voor Farmacotherapie bij Kinderen) (2017) Developing a paediatric drug formulary for the Netherlands. Arch Dis Child 102:357\u2013361. https:\/\/doi.org\/10.1136\/archdischild-2016-311674","journal-title":"Arch Dis Child"},{"key":"7420_CR32","unstructured":"Certara (2023) Simcyp simulator. https:\/\/www.certara.com\/software\/simcyp-pbpk. Accessed 07 Nov 2025"},{"key":"7420_CR33","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s00467-008-0997-5","volume":"24","author":"MM Rhodin","year":"2009","unstructured":"Rhodin MM, Anderson BJ, Peters AM, Coulthard MG, Wilkins B, Cole M, Chatelut E, Grubb A, Veal GJ, Keir MJ, Holford NH\u00a0(2009) Human renal function maturation: a quantitative description using weight and postmenstrual age. Pediatr Nephrol 24:67\u201376.\u00a0https:\/\/doi.org\/10.1007\/s00467-008-0997-5","journal-title":"Pediatr Nephrol"},{"key":"7420_CR34","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1172\/jci102149","volume":"28","author":"MI Rubin","year":"1949","unstructured":"Rubin MI, Bruck E, Rapoport M, Snively M, McKay H, Baumler A (1949) Maturation of renal function in childhood: clearance studies. J Clin Invest 28:1144\u20131162.\u00a0https:\/\/doi.org\/10.1172\/jci102149","journal-title":"J Clin Invest"},{"key":"7420_CR35","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1681\/asn.2021101326","volume":"33","author":"NJL Smeets","year":"2022","unstructured":"Smeets NJL, IntHout J, van der Burgh MJP, Schwartz GJ, Schreuder MF, de Wildt SN\u00a0(2022) Maturation of GFR in term-born neonates: an individual participant data meta-analysis. J Am Soc Nephrol 33:1277\u20131292.\u00a0https:\/\/doi.org\/10.1681\/asn.2021101326","journal-title":"J Am Soc Nephrol"},{"key":"7420_CR36","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1007\/s00259-006-0179-2","volume":"33","author":"A Piepsz","year":"2006","unstructured":"Piepsz A, Tondeur M, Ham H (2006) Revisiting normal (51)Cr-ethylenediaminetetraacetic acid clearance values in children. Eur J Nucl Med Mol Imaging 33:1477\u20131482.\u00a0https:\/\/doi.org\/10.1007\/s00259-006-0179-2","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7420_CR37","unstructured":"Dutch Society of Pediatrics (n.d.) Kinderformularium: gentamicine. https:\/\/www.kinderformularium.nl\/geneesmiddel\/23\/gentamicine. Accessed 07 Nov 2025"},{"key":"7420_CR38","unstructured":"World Health Organization (2006) WHO child growth standards. https:\/\/www.who.int\/toolkits\/child-growth-standards\/standards. Accessed 07 Nov 2025"},{"key":"7420_CR39","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/S0022-3476(78)80601-5","volume":"93","author":"GB Haycock","year":"1978","unstructured":"Haycock GB, Schwartz GJ, Wisotsky DH (1978) Geometric method for measuring body surface area: a height-weight formula validated in infants, children, and adults. J Pediatr 93:62\u201366.\u00a0https:\/\/doi.org\/10.1016\/S0022-3476(78)80601-5","journal-title":"J Pediatr"},{"key":"7420_CR40","unstructured":"Python Software Foundation (2025) Python 3.15 reference manual. https:\/\/docs.python.org\/3\/reference\/index.html. Accessed 07 Nov 2025"},{"key":"7420_CR41","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1093\/jac\/dkl561","volume":"59","author":"C Seaton","year":"2007","unstructured":"Seaton C, Ignas J, Muchohi S, Kokwaro G, Maitland K, Thomson AH\u00a0(2007) Population pharmacokinetics of a single daily intramuscular dose of gentamicin in children with severe malnutrition. J Antimicrob Chemother 59:681\u2013689.\u00a0https:\/\/doi.org\/10.1093\/jac\/dkl561","journal-title":"J Antimicrob Chemother"},{"key":"7420_CR42","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.jiac.2020.09.033","volume":"27","author":"T Yamada","year":"2021","unstructured":"Yamada T, Fujii S, Shigemi A, Takesue Y (2021) A meta-analysis of the target trough concentration of gentamicin and amikacin for reducing the risk of nephrotoxicity. J Infect Chemother 27:256\u2013261.\u00a0https:\/\/doi.org\/10.1016\/j.jiac.2020.09.033","journal-title":"J Infect Chemother"},{"key":"7420_CR43","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1007\/s40262-022-01143-0","volume":"61","author":"CJ Hodiamont","year":"2022","unstructured":"Hodiamont CJ, van den Broek AK, de Vroom SL, Prins JM, Math\u00f4t RAA, van Hest RM\u00a0(2022) Clinical pharmacokinetics of gentamicin in various patient populations and consequences for optimal dosing for Gram-negative infections: an updated review. Clin Pharmacokinet 61:1075\u20131094.\u00a0https:\/\/doi.org\/10.1007\/s40262-022-01143-0","journal-title":"Clin Pharmacokinet"},{"key":"7420_CR44","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1111\/bcp.15978","volume":"90","author":"N Holford","year":"2024","unstructured":"Holford N, O'Hanlon CJ, Allegaert K, Anderson B, Falc\u00e3o A, Simon N, Lo YL, Thomson AH, Sherwin CM, Jacqz-Aigrain E, Llanos-Paez C, Hennig S, Mockus L, Kirkpatrick C\u00a0(2024) A physiological approach to renal clearance: from premature neonates to adults. Br J Clin Pharmacol 90:1066\u20131080.\u00a0https:\/\/doi.org\/10.1111\/bcp.15978","journal-title":"Br J Clin Pharmacol"},{"key":"7420_CR45","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s00467-018-4067-3","volume":"34","author":"CL Salvador","year":"2019","unstructured":"Salvador CL, T\u00f8ndel C, Rowe AD, Bjerre A, Brun A, Brackman D, M\u00f8rkrid L\u00a0(2019) Estimating glomerular filtration rate in children: evaluation of creatinine- and cystatin C-based equations. Pediatr Nephrol 34:301\u2013311.\u00a0https:\/\/doi.org\/10.1007\/s00467-018-4067-3","journal-title":"Pediatr Nephrol"},{"key":"7420_CR46","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1093\/jac\/dkz408","volume":"75","author":"SN Avedissian","year":"2020","unstructured":"Avedissian SN, Rhodes NJ, Kim Y, Bradley J, Valdez JL, Le J\u00a0(2020) Augmented renal clearance of aminoglycosides using population-based pharmacokinetic modelling with Bayesian estimation in the paediatric ICU. J Antimicrob Chemother 75:162\u2013169.\u00a0https:\/\/doi.org\/10.1093\/jac\/dkz408","journal-title":"J Antimicrob Chemother"},{"key":"7420_CR47","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1177\/0310057x0903700611","volume":"37","author":"TE Jones","year":"2009","unstructured":"Jones TE, Peter JV, Field J\u00a0(2009) Aminoglycoside clearance is a good estimate of creatinine clearance in intensive care unit patients. Anaesth Intensive Care 37:944\u2013952.\u00a0https:\/\/doi.org\/10.1177\/0310057x0903700611","journal-title":"Anaesth Intensive Care"},{"key":"7420_CR48","doi-asserted-by":"publisher","first-page":"941","DOI":"10.2215\/cjn.01250119","volume":"14","author":"K Kashani","year":"2019","unstructured":"Kashani K, Rosner MH, Haase M, Lewington AJP, O'Donoghue DJ, Wilson FP, Nadim MK, Silver SA, Zarbock A, Ostermann M, Mehta RL, Kane-Gill SL, Ding X, Pickkers P, Bihorac A, Siew ED, Barreto EF, Macedo E, Kellum JA, Palevsky PM, Tolwani AJ, Ronco C, Juncos LA, Rewa OG, Bagshaw SM, Mottes TA, Koyner JL, Liu KD, Forni LG, Heung M, Wu VC\u00a0(2019) Quality improvement goals for acute kidney injury. Clin J Am Soc Nephrol 14:941\u2013953.\u00a0https:\/\/doi.org\/10.2215\/cjn.01250119","journal-title":"Clin J Am Soc Nephrol"},{"key":"7420_CR49","doi-asserted-by":"publisher","first-page":"5699","DOI":"10.2174\/1381612821666150901110659","volume":"21","author":"K Allegaert","year":"2015","unstructured":"Allegaert K, Cossey V, van den Anker JN\u00a0(2015) Dosing guidelines of aminoglycosides in neonates: a balance between physiology and feasibility. Curr Pharm Des 21:5699\u20135704.\u00a0https:\/\/doi.org\/10.2174\/1381612821666150901110659","journal-title":"Curr Pharm Des"},{"key":"7420_CR50","doi-asserted-by":"publisher","first-page":"4143","DOI":"10.1007\/s00431-023-05103-z","volume":"182","author":"R Velarde-Salcedo","year":"2023","unstructured":"Velarde-Salcedo R, P\u00e9rez-Gonz\u00e1lez LF, Rodr\u00edguez-B\u00e1ez AS, Arriaga-Garc\u00eda FJ, Mil\u00e1n-Segovia RDC, Romano-Moreno S, Medell\u00edn-Garibay SE\u00a0(2023) Model-informed precision dosing of antimicrobial drugs in pediatrics: experiences from a pilot scale program. Eur J Pediatr 182:4143\u20134152.\u00a0https:\/\/doi.org\/10.1007\/s00431-023-05103-z","journal-title":"Eur J Pediatr"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-026-07420-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00467-026-07420-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-026-07420-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T22:54:11Z","timestamp":1792104851000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00467-026-07420-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,7]]},"references-count":50,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["7420"],"URL":"https:\/\/doi.org\/10.1007\/s00467-026-07420-5","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,7]]},"assertion":[{"value":"3 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"An ethics approval is not applicable as this study only used published, de-identified data.","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable, as this is an in silico study.","order":2,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable, as this is an in silico study.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"FJM and DHF are employees of Fresenius Medical Care Deutschland GmbH. ACAE and RH are employees of Fresenius Medical Care Holdings Inc.","order":4,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}